Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

06/16/11 Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.        

06/16/11 Tumor treating fields: concept, evidence and future.        

06/16/11 Specialised Therapeutics to License Brain Tumour Visualisation Drug Gliolan in Australia & NZ        

06/16/11 Engineering the brain tumor microenvironment enhances the efficacy of dendritic cells' vaccination: implications for clinical trials design.        

06/16/11 Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience.        

06/16/11 Voices Against Brain Cancer's Annual Gala in NY is tonight!        

06/14/11 "Navigating the Insurance Maze " - a free seminar for individuals and families coping with all types of brain tumors        

06/13/11 Stemline Therapeutics Announces Oral Presentation of Positive Phase I/II Trial Results with Novel Brain Cancer Vaccine at ASCO        

06/10/11 FDA Gives Green Light to Simultaneous PET/MRI System        

06/10/11 Lakefest Fundraiser June 25th, Dallas/ Ft Worth!        

06/07/11 Tocagen's First-in-Human Clinical Trial of Toca 511 Enrolling Patients with High Grade Glioma        

06/07/11 Treatment with OPAXIO® (Paclitaxel Poliglumex),Temozolomide and Radiotherapy Results in Encouraging Progression Free Survival in Patients With High Grade Malignant Brain Tumor        

06/06/11 Antifungal Drug Delays Need For Chemo In Advanced Prostate Cancer        

06/06/11 New technique hopeful option for treating cancer        

06/06/11 New Data From Phase 2 Brain Cancer Study With Prophage Series G-200 (HSPPC-96) Shows Improved Overall Survival        

06/05/11 Free summer program for kids and teens impacted by brain tumors        

06/04/11 Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times        

06/04/11 NICO Corporation Receives Health Canada Approval for Brain Tumor Removal Tool        

06/02/11 Bevacizumab (Avastin)-induced hypertension: pathogenesis and management.        

---

Displaying Stories 2721 to 2740 of 7673
Previous 20           Next 20